- Home
- XOS vs ALDX Comparison
XOS vs ALDX Comparison
Compare XOS & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XOS | ALDX |
|---|---|---|
| Founded | 2016 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.4M | 39.2M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | XOS | ALDX |
|---|---|---|
| Price | $2.66 | $0.63 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $6.60 |
| AVG Volume (30 Days) | 144.5K | ★ 1.8M |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.49 | 40.43 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $45,992,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.30 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.60 | $0.60 |
| 52 Week High | $8.27 | $5.93 |
Technical Indicators
Market Signals| Indicator | XOS | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 38.90 | 26.66 |
| Support Level | $2.45 | N/A |
| Resistance Level | $3.07 | $1.58 |
| Average True Range (ATR) | 0.22 | 0.07 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 10.99 | 9.82 |
Price Performance
Historical ComparisonAbout XOS Xos Inc.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Class 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.